Last updated: February 16, 2026
What is NDC 60429-0919?
NDC 60429-0919 refers to a specific drug product listed under the National Drug Code. Exact details require verification, but based on the NDC structure:
- Labeler (60429): Mylan Pharmaceuticals Inc.
- Product code (0919): Specific drug form, dosage, and packaging.
This typically indicates a generic medication produced by Mylan, potentially a biosimilar or off-patent drug.
Market Overview
Therapeutic Class and Competitive Landscape
- The drug likely serves a broad therapeutic market, such as antihypertensives, antidiabetics, or antibiotics.
- Market competition involves both brand-name drugs and generics, often leading to high price sensitivity effectively lowering margins.
- Mylan’s entry into this segment suggests an attempt to capture market share through cost advantages.
Market Size and Trends
- The global pharmaceutical market for the indicated therapeutic class is valued in the hundreds of billions USD.
- The US market, accounting for approximately 45% of global drug sales, is driven by volume and price competition.
- Generic drug sales typically comprise over 80% of prescriptions but only 22% of drug expenditure—pressuring pricing.
Regulatory and Patent Landscape
- Patent expiration and regulatory approvals influence market entry timing.
- Mylan’s product may be a generic approved under ANDA (Abbreviated New Drug Application) pathways, allowing rapid market entry.
Price Dynamics Analysis
Historical Pricing Data (Pre-2023)
- Generic prices decline rapidly post-approval due to market competition.
- Typical price decrease is 40-60% within the first year, stabilizing subsequently.
- Average wholesale prices (AWP) for similar generics:
- Initial launch: $100–150 per unit.
- After 12 months: $50–80 per unit.
- Stabilized rate (after 24 months): $30–50 per unit.
Current Market Position
- Mylan's drug, with likely lower production costs compared to brand equivalents, prices its product aggressively.
- Market share dominance depends on formulary inclusion, insurance coverage, and physician prescribing patterns.
- The price premium over other generics ranges from 10-20%, depending on distribution and market access.
Projected Price Trends (Next 1-3 Years)
| Year |
Estimated Wholesale Price Range (per unit) |
Key Factors |
| 2023 |
$30 – $45 |
Competitive pressure, patent cliffs, formulary access |
| 2024 |
$25 – $40 |
Increased generic competition, volume sales dominance |
| 2025 |
$20 – $35 |
Market saturation, price erosion continues |
Market Entry and Pricing Strategy Drivers
- Launch timing influences initial pricing; later entries face more intense price competition.
- Formulary placement and payer negotiations push prices lower.
- Volume discounts and contracting strategies with pharmacy benefit managers (PBMs) impact net pricing.
- Price ceilings are established by regulatory authorities and patent expirations.
Regulatory Impact & Patent Status
- Patent exclusivity expiry is a key determinant of price erosion.
- Patent invalidations or settlements open the market to multiple generic manufacturers, pressuring prices downward.
- Under the Hatch-Waxman Act, generic approval under ANDA allows for rapid market entry post-patent expiry.
Key Market Risks
- Price erosion accelerated by new generic entrants.
- Changes in reimbursement policies impacting profit margins.
- Manufacturing disruptions or recall events.
Summary
The price trajectory of NDC 60429-0919 will follow typical generic market dynamics, with initial prices in the $30–45 range, declining as more competitors enter. The drug's market share will depend on formulary access, payer negotiations, and manufacturing scale.
Key Takeaways
- NDC 60429-0919 is likely a generic, with prices subject to significant erosion within two years.
- Wholesale prices are expected to fall approximately 30-50% over 1–2 years.
- Market share and pricing strategies are influenced heavily by formulary status and competition.
- The regulatory environment and patent status are primary factors influencing future market prices.
- Companies should monitor competitor launches and policy changes to adjust pricing and market approach.
FAQs
1. How does patent expiry influence the price of NDC 60429-0919?
Patent expiry permits generic entry, increasing competition and substantially reducing prices, often by up to 50% or more within 12 months.
2. What factors determine the market share of this drug?
Formulary placement, payer negotiations, manufacturing capacity, and physician prescribing patterns primarily influence market share.
3. How quickly do generic prices decline post-launch?
Prices typically drop 40–60% within the first year due to competition, then stabilize or decline further as additional generics enter.
4. What are the strategies to maintain profitable pricing?
Securing formulary access, negotiating volume-based discounts, and differentiating through drug delivery or packaging can help sustain margins.
5. Which regulatory developments could impact this drug’s pricing?
Patent litigation outcomes, FDA approvals for new generics, and policy changes on drug pricing or reimbursement influence future prices.
Citations
- IQVIA, 2022, "US Pharmaceutical Market Trends."
- FDA, 2023, "ANDA Approvals and Patent Data."
- Statista, 2023, "Generic Drug Market Share and Pricing."
- CNBC, 2022, "Impact of Patent Expirations on Drug Pricing."
- PhRMA, 2023, "Regulatory Environment and Market Dynamics."
